{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:32:13Z","timestamp":1792179133175,"version":"4.4.0"},"reference-count":299,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T00:00:00Z","timestamp":1774137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>Alzheimer\u2019s disease (AD), the leading cause of global dementia, is a multifactorial process that goes beyond the accumulation of \u03b2-amyloid (A\u03b2) plaques and tau protein tangles, including glia cell-mediated neuroinflammation, vascular dysfunction, metabolic alterations, and synaptic loss. Its complex etiology also involves oxidative stress and mitochondrial dysfunction. Multiple neurotransmitter systems involved in the pathogenesis and the various cognitive and non-cognitive symptoms of AD are thus altered. The cholinergic system, historically the first to be associated with AD, suffers early degeneration and loss of neurons\/receptors, correlating with cognitive impairment. The glutamatergic system, the main excitatory system, exhibits excitotoxicity due to increased extracellular glutamate and alterations in NMDA\/AMPA receptor distribution, exacerbating neuronal damage. The GABAergic system, the main inhibitor, shows alterations in parvalbumin-positive interneurons, leading to hyperexcitability and dysfunction of neuronal networks. Monoaminergic systems (serotonergic, dopaminergic and noradrenergic) undergo early degeneration in key nuclei such as the raphe and locus coeruleus, contributing to the apathy, depression and sleep disturbances characteristic of AD. Other less explored systems, such as histaminergic and purinergic, are also crucial in cognitive modulation and neuroinflammation. The endocannabinoid system acts as a master modulator with neuroprotective and anti-inflammatory effects. These systems do not operate in isolation; their complex interactions generate pathological circuits that amplify neuronal dysfunction. The limited efficacy of current therapies, which are primarily symptomatic, highlights the need for multimodal approaches that may transform AD treatment toward personalized and more effective interventions.<\/jats:p>","DOI":"10.3390\/cimb48030334","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T11:59:36Z","timestamp":1774267176000},"page":"334","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Neurotransmitter Systems in Alzheimer\u2019s Disease"],"prefix":"10.3390","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9379-203X","authenticated-orcid":false,"given":"Mar\u00eda Jes\u00fas","family":"Ram\u00edrez-Exp\u00f3sito","sequence":"first","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6149-090X","authenticated-orcid":false,"given":"Cristina","family":"Cueto-Ure\u00f1a","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2950-5614","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Mart\u00ednez-Martos","sequence":"additional","affiliation":[{"name":"Experimental and Clinical Physiopathology Research Group CTS-1039, Department of Health Sciences, School of Health Sciences, University of Ja\u00e9n, E23071 Ja\u00e9n, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,22]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"148797","DOI":"10.1016\/j.brainres.2024.148797","article-title":"The neurotransmitter puzzle of Alzheimer\u2019s: Dissecting mechanisms and exploring therapeutic horizons","volume":"1829","author":"Sharma","year":"2024","journal-title":"Brain Res."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"(2025). 2025 Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement., 21, e70235.","DOI":"10.1002\/alz.70235"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Hao, M., and Chen, J. (2025). Trend analysis and future predictions of global burden of alzheimer\u2019s disease and other dementias: A study based on the global burden of disease database from 1990 to 2021. BMC Med., 23.","DOI":"10.1186\/s12916-025-04169-w"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"102481","DOI":"10.1016\/j.arr.2024.102481","article-title":"Pathogenesis, diagnostics, and therapeutics for Alzheimer\u2019s disease: Breaking the memory barrier","volume":"101","author":"Kamatham","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"ref_5","first-page":"101106","article-title":"Temporal trends and disparities of population attributable fractions of modifiable risk factors for dementia in China: A time-series study of the China health and retirement longitudinal study (2011-2018)","volume":"47","author":"Chen","year":"2024","journal-title":"Lancet Reg. Health West Pac."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer\u2019s disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s11011-023-01242-2","article-title":"Imbalance of multiple neurotransmitter pathways leading to depression-like behavior and cognitive dysfunction in the triple transgenic mouse model of Alzheimer disease","volume":"38","author":"Zhang","year":"2023","journal-title":"Metab. Brain Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/brain\/awab375","article-title":"Personalized brain models identify neurotransmitter receptor changes in Alzheimer\u2019s disease","volume":"145","author":"Khan","year":"2022","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3233\/JAD-230150","article-title":"The Multifactorial Etiopathogenesis of Alzheimer\u2019s Disease: Neuroinflammation as the Major Contributor","volume":"94","author":"Gonzalez","year":"2023","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Kazemeini, S., Nadeem-Tariq, A., Shih, R., Rafanan, J., Ghani, N., and Vida, T.A. (2024). From Plaques to Pathways in Alzheimer\u2019s Disease: The Mitochondrial-Neurovascular-Metabolic Hypothesis. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252111720"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nrn3114","article-title":"Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders","volume":"12","author":"Zlokovic","year":"2011","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Czapski, G.A., and Strosznajder, J.B. (2021). Glutamate and GABA in Microglia-Neuron Cross-Talk in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222111677"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1001\/jamaneurol.2023.3530","article-title":"Tau Oligomer-Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease","volume":"80","author":"Taddei","year":"2023","journal-title":"JAMA Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Liu, J., Chang, L., Song, Y., Li, H., and Wu, Y. (2019). The Role of NMDA Receptors in Alzheimer\u2019s Disease. Front. Neurosci., 13.","DOI":"10.3389\/fnins.2019.00043"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e25380","DOI":"10.1002\/jnr.25380","article-title":"The Endocannabinoid System in Alzheimer\u2019s Disease: A Network Meta-Analysis","volume":"102","author":"Liu","year":"2024","journal-title":"J. Neurosci. Res."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Yang, Z., Zou, Y., and Wang, L. (2023). Neurotransmitters in Prevention and Treatment of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24043841"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41380-024-02691-6","article-title":"Melatonin: A potential nighttime guardian against Alzheimer\u2019s","volume":"30","author":"Zhang","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.semcdb.2021.01.005","article-title":"GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer\u2019s disease","volume":"116","author":"Eich","year":"2021","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"bhaf053","DOI":"10.1093\/cercor\/bhaf053","article-title":"Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer\u2019s disease","volume":"35","author":"Nabizadeh","year":"2025","journal-title":"Cereb. Cortex"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s12035-024-04333-y","article-title":"An Expanded Narrative Review of Neurotransmitters on Alzheimer\u2019s Disease: The Role of Therapeutic Interventions on Neurotransmission","volume":"62","author":"Akyuz","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/1381612819666140110115603","article-title":"NMDA neurotransmission dysfunction in mild cognitive impairment and Alzheimer\u2019s disease","volume":"20","author":"Lin","year":"2014","journal-title":"Curr. Pharm. Des."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"137816","DOI":"10.1016\/j.neulet.2024.137816","article-title":"Genes related to neurotransmitter receptors as potential biomarkers for Alzheimer\u2019s disease","volume":"832","author":"Chen","year":"2024","journal-title":"Neurosci. Lett."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zhang, N.K., Zhang, S.K., Zhang, L.I., Tao, H.W., and Zhang, G.W. (2024). The neural basis of neuropsychiatric symptoms in Alzheimer\u2019s disease. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1487875"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.niox.2023.03.003","article-title":"Dual role of nitric oxide in Alzheimer\u2019s disease","volume":"134\u2013135","author":"Azargoonjahromi","year":"2023","journal-title":"Nitric Oxide"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.neuint.2004.03.009","article-title":"The NOS\/sGC pathway in the rat central nervous system: A microdialysis overview","volume":"45","author":"Pepicelli","year":"2004","journal-title":"Neurochem. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s43587-024-00599-y","article-title":"Disease staging of Alzheimer\u2019s disease using a CSF-based biomarker model","volume":"4","author":"Salvado","year":"2024","journal-title":"Nat. Aging"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.neurobiolaging.2010.09.013","article-title":"Serum fatty acid profiles using GC-MS and multivariate statistical analysis: Potential biomarkers of Alzheimer\u2019s disease","volume":"33","author":"Wang","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.3233\/ADR-240104","article-title":"The Association Between Brain Metabolic Biomarkers Using (18)F-FDG and Cognition and Vascular Risk Factors, as well as Its Usefulness in the Diagnosis and Staging of Alzheimer\u2019s Disease","volume":"8","author":"Xiong","year":"2024","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Cheng, Y.J., Lin, C.H., and Lane, H.Y. (2021). Involvement of Cholinergic, Adrenergic, and Glutamatergic Network Modulation with Cognitive Dysfunction in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052283"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/10738584211069897","article-title":"Recent Insights on Glutamatergic Dysfunction in Alzheimer\u2019s Disease and Therapeutic Implications","volume":"29","author":"Pinky","year":"2023","journal-title":"Neuroscientist"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.3233\/JAD-201195","article-title":"Retinal Ganglion Cells Functional Changes in a Mouse Model of Alzheimer\u2019s Disease Are Linked with Neurotransmitter Alterations","volume":"82","author":"Bello","year":"2021","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-190577","article-title":"Neurotransmitter Imbalance in the Brain and Alzheimer\u2019s Disease Pathology","volume":"72","author":"Snowden","year":"2019","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer\u2019s disease: Targeting the Cholinergic System","volume":"14","author":"Guimaraes","year":"2016","journal-title":"Curr. Neuropharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jiao, L., Kang, H., Geng, Y., Liu, X., Wang, M., and Shu, K. (2024). The role of the nucleus basalis of Meynert in neuromodulation therapy: A systematic review from the perspective of neural network oscillations. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1376764"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"fcaf008","DOI":"10.1093\/braincomms\/fcaf008","article-title":"Changes in neurotransmitter-related functional connectivity along the Alzheimer\u2019s disease continuum","volume":"7","author":"Manca","year":"2025","journal-title":"Brain Commun."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"8231","DOI":"10.1002\/alz.14125","article-title":"Synaptic and extrasynaptic distribution of NMDA receptors in the cortex of Alzheimer\u2019s disease patients","volume":"20","author":"Escamilla","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s12276-023-01148-0","article-title":"Pathological phenotypes of astrocytes in Alzheimer\u2019s disease","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-022-04687-y","article-title":"Amyloid beta\/PKC-dependent alterations in NMDA receptor composition are detected in early stages of Alzheimer s disease","volume":"13","author":"Balantzategi","year":"2022","journal-title":"Cell Death Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1038\/s41467-024-47028-7","article-title":"Native-state proteomics of Parvalbumin interneurons identifies unique molecular signatures and vulnerabilities to early Alzheimer\u2019s pathology","volume":"15","author":"Kumar","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/nrn.2016.141","article-title":"Network abnormalities and interneuron dysfunction in Alzheimer disease","volume":"17","author":"Palop","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41538-025-00423-w","article-title":"Long-term GABA supplementation mitigates anxiety by modulating complement and neuroinflammatory pathways","volume":"9","author":"Xu","year":"2025","journal-title":"npj Sci. Food"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Xu, Y., Zhao, M., Han, Y., and Zhang, H. (2020). GABAergic Inhibitory Interneuron Deficits in Alzheimer\u2019s Disease: Implications for Treatment. Front. Neurosci., 14.","DOI":"10.3389\/fnins.2020.00660"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/sj.npp.1300330","article-title":"Differential involvement of 5-HT(1B\/1D) and 5-HT6 receptors in cognitive and non-cognitive symptoms in Alzheimer\u2019s disease","volume":"29","author":"Hirst","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ana.410400512","article-title":"Deficient glutamate transport is associated with neurodegeneration in Alzheimer\u2019s disease","volume":"40","author":"Masliah","year":"1996","journal-title":"Ann. Neurol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/s41380-024-02664-9","article-title":"Tau pathology in the dorsal raphe may be a prodromal indicator of Alzheimer\u2019s disease","volume":"30","author":"Pierson","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s11357-024-01359-x","article-title":"Monoamine alterations in Alzheimer\u2019s disease and their implications in comorbid neuropsychiatric symptoms","volume":"47","author":"Saggu","year":"2025","journal-title":"Geroscience"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1038\/s41467-024-53891-1","article-title":"VTA dopamine neurons are hyperexcitable in 3xTg-AD mice due to casein kinase 2-dependent SK channel dysfunction","volume":"15","author":"Blankenship","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"fcae204","DOI":"10.1093\/braincomms\/fcae204","article-title":"Chronic inflammation with microglia senescence at basal forebrain: Impact on cholinergic deficit in Alzheimer\u2019s brain haemodynamics","volume":"6","author":"Liu","year":"2024","journal-title":"Brain Commun."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s42003-022-03434-5","article-title":"Cortical D1 and D2 dopamine receptor availability modulate methylphenidate-induced changes in brain activity and functional connectivity","volume":"5","author":"Manza","year":"2022","journal-title":"Commun. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1038\/s41380-024-02408-9","article-title":"Dopamine neuron degeneration in the Ventral Tegmental Area causes hippocampal hyperexcitability in experimental Alzheimer\u2019s Disease","volume":"29","author":"Spoleti","year":"2024","journal-title":"Mol. Psychiatry"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1146\/annurev.neuro.28.061604.135709","article-title":"An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance","volume":"28","author":"Cohen","year":"2005","journal-title":"Annu. Rev. Neurosci."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Mercan, D., and Heneka, M.T. (2022). The Contribution of the Locus Coeruleus-Noradrenaline System Degeneration during the Progression of Alzheimer\u2019s Disease. Biology, 11.","DOI":"10.3390\/biology11121822"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.4103\/1673-5374.235219","article-title":"Targeting the noradrenergic system for anti-inflammatory and neuroprotective effects: Implications for Parkinson\u2019s disease","volume":"13","author":"Harkin","year":"2018","journal-title":"Neural Regen. Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/B978-0-12-820107-7.00023-9","article-title":"Histamine receptors, agonists, and antagonists in health and disease","volume":"Volume 180","author":"Panula","year":"2021","journal-title":"Handbook of Clinical Neurology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0306-4522(97)00353-9","article-title":"Neuronal histamine deficit in Alzheimer\u2019s disease","volume":"82","author":"Panula","year":"1998","journal-title":"Neuroscience"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"9887","DOI":"10.1038\/s41467-024-54347-2","article-title":"Histamine-tuned subicular circuit mediates alert-driven accelerated locomotion in mice","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-030-30651-9_1","article-title":"Introduction to Purinergic Signalling in the Brain","volume":"Volume 1202","author":"Burnstock","year":"2020","journal-title":"Glioma Signaling"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-4939-9717-6_1","article-title":"Introduction to Purinergic Signaling","volume":"Volume 2041","author":"Burnstock","year":"2020","journal-title":"Purinergic Signaling"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gessi, S., Poloni, T.E., Negro, G., Varani, K., Pasquini, S., Vincenzi, F., Borea, P.A., and Merighi, S. (2021). A(2A) Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer\u2019s Disease. Cells, 10.","DOI":"10.3390\/cells10092344"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Islam, J., Cho, J.A., Kim, J.Y., Park, K.S., Koh, Y.J., Chung, C.Y., Lee, E.J., Nam, S.J., Lee, K., and Kim, S.H. (2022). GPCR19 Regulates P2X7R-Mediated NLRP3 Inflammasomal Activation of Microglia by Amyloid beta in a Mouse Model of Alzheimer\u2019s Disease. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.766919"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/mp.2014.151","article-title":"A2A adenosine receptor deletion is protective in a mouse model of Tauopathy","volume":"21","author":"Laurent","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3233\/JAD-131910","article-title":"Altered expression of the CB1 cannabinoid receptor in the triple transgenic mouse model of Alzheimer\u2019s disease","volume":"40","author":"Bedse","year":"2014","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"11136","DOI":"10.1523\/JNEUROSCI.23-35-11136.2003","article-title":"Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer\u2019s disease brains","volume":"23","author":"Benito","year":"2003","journal-title":"J. Neurosci."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1111\/febs.17403","article-title":"Fatty-acid amide hydrolase inhibition mitigates Alzheimer\u2019s disease progression in mouse models of amyloidosis","volume":"292","author":"Oddi","year":"2025","journal-title":"FEBS J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exger.2012.05.019","article-title":"Plasma oxidative stress parameters in men and women with early stage Alzheimer type dementia","volume":"47","author":"Puertas","year":"2012","journal-title":"Exp. Gerontol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41398-025-03458-5","article-title":"Complement C1q is associated with neuroinflammation and mediates the association between amyloid-beta and tau pathology in Alzheimer\u2019s disease","volume":"15","author":"Guo","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e2400149","DOI":"10.1002\/adhm.202400149","article-title":"Systemic Administration of Neurotransmitter-Derived Lipidoids-PROTACs-DNA Nanocomplex Promotes Tau Clearance and Cognitive Recovery for Alzheimer\u2019s Disease Therapy","volume":"13","author":"Gong","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/cm.21822","article-title":"Tau and Alzheimer\u2019s disease: Past, present and future","volume":"81","author":"Iqbal","year":"2024","journal-title":"Cytoskeleton"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuropharm.2016.01.002","article-title":"Abeta-mediated spine changes in the hippocampus are microtubule-dependent and can be reversed by a subnanomolar concentration of the microtubule-stabilizing agent epothilone D","volume":"105","author":"Penazzi","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1038\/s41380-025-02901-9","article-title":"Synaptic vulnerability to amyloid-beta and tau pathologies differentially disrupts emotional and memory neural circuits","volume":"30","author":"Deprada","year":"2025","journal-title":"Mol. Psychiatry"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13195-025-01711-z","article-title":"Tau-PET pathology in the subregions of the amygdala and its associations with cognitive performance and neuropsychiatric symptoms in autosomal dominant Alzheimer\u2019s disease","volume":"17","author":"Langella","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Cao, Y., Tang, K., Ma, P., Zhang, R., Yang, Y., Li, T., Zhang, Y., and Peng, X. (2025). The role of peripheral innate immune cells in Alzheimer\u2019s disease progression. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1616939"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13024-025-00834-z","article-title":"TREM2 and sTREM2 in Alzheimer\u2019s disease: From mechanisms to therapies","volume":"20","author":"Zhang","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s43587-022-00204-0","article-title":"Biomarker modeling of Alzheimer\u2019s disease using PET-based Braak staging","volume":"2","author":"Therriault","year":"2022","journal-title":"Nat. Aging"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"e213675","DOI":"10.1212\/WNL.0000000000213675","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Validating the Amyloid Cascade Through the Revised Criteria of Alzheimer\u2019s Association Workgroup 2024 for Alzheimer Disease","volume":"104","author":"Mendes","year":"2025","journal-title":"Neurology"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.neurobiolaging.2021.03.010","article-title":"Implications for microglial sex differences in tau-related neurodegenerative diseases","volume":"105","author":"Doust","year":"2021","journal-title":"Neurobiol. Aging"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Ahmed, G., Rahaman, M.S., Perez, E., and Khan, K.M. (2025). Associations of Environmental Exposure to Arsenic, Manganese, Lead, and Cadmium with Alzheimer\u2019s Disease: A Review of Recent Evidence from Mechanistic Studies. J. Xenobiot., 15.","DOI":"10.20944\/preprints202501.2241.v1"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s10787-025-01765-3","article-title":"Role of mGluR7 in Alzheimer\u2019s disease: Pathophysiological insights and therapeutic approaches","volume":"33","author":"Hunjan","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Xing, H., Yue, S., Qin, R., Du, X., Wu, Y., Zhangsun, D., and Luo, S. (2025). Recent Advances in Drug Development for Alzheimer\u2019s Disease: A Comprehensive Review. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26083905"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"e70051","DOI":"10.1002\/alz.70051","article-title":"Astrocytes, via RTP801, contribute to cognitive decline by disrupting GABAergic-regulated connectivity and driving neuroinflammation in an Alzheimer\u2019s disease mouse model","volume":"21","author":"Perez","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"e51696","DOI":"10.15252\/embr.202051696","article-title":"SFRP1 modulates astrocyte-to-microglia crosstalk in acute and chronic neuroinflammation","volume":"22","author":"Pereyra","year":"2021","journal-title":"EMBO Rep."},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Curtis, D., Joseph, S., and Alzheimer\u2019s Disease Neuroimaging Initiative (2025). Analysis of whole genome sequence data shows association of Alzheimer\u2019s disease with rare coding variants in ABCA7, PSEN1, SORL1 and TREM2. medRxiv.","DOI":"10.1101\/2025.07.27.25332260"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"24968","DOI":"10.1038\/s41598-025-09563-1","article-title":"Microglial exosome TREM2 ameliorates ferroptosis and neuroinflammation in alzheimer\u2019s disease by activating the Wnt\/beta-catenin signaling","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13195-025-01700-2","article-title":"TREM2 risk variants and associated endophenotypes in alzheimer\u2019s disease","volume":"17","author":"Dijkstra","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_86","doi-asserted-by":"crossref","unstructured":"Golovynska, I., Chen, Q., Stepanov, Y.V., Lin, D., and Qu, J. (2025). Amyloid-induced mitochondrial network disruption in neurons monitored by STED super-resolution imaging. Front. Cell Dev. Biol., 13.","DOI":"10.3389\/fcell.2025.1610204"},{"key":"ref_87","doi-asserted-by":"crossref","unstructured":"Misrani, A., Tabassum, S., and Yang, L. (2021). Mitochondrial Dysfunction and Oxidative Stress in Alzheimer\u2019s Disease. Front. Aging Neurosci., 13.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Wang, S., Liao, Z., Zhang, Q., Han, X., Liu, C., and Wang, J. (2024). Mitochondrial dysfunction in Alzheimer\u2019s disease: A key frontier for future targeted therapies. Front. Immunol., 15.","DOI":"10.3389\/fimmu.2024.1484373"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1111\/bph.14585","article-title":"Mitochondrial dysfunction in Alzheimer\u2019s disease: Role in pathogenesis and novel therapeutic opportunities","volume":"176","author":"Swerdlow","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbadis.2013.10.015","article-title":"Oxidative stress and mitochondrial dysfunction in Alzheimer\u2019s disease","volume":"1842","author":"Wang","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"6785","DOI":"10.1007\/s12035-024-04468-y","article-title":"Exploring the Mechanisms and Therapeutic Approaches of Mitochondrial Dysfunction in Alzheimer\u2019s Disease: An Educational Literature Review","volume":"62","author":"Moawad","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_92","first-page":"e70050","article-title":"The Common Alzheimer\u2019s Disease Research Ontology (CADRO) for biomarker categorization","volume":"11","author":"Kinney","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1093\/cercor\/bhad201","article-title":"Spatiotemporal topological correspondence between blood oxygenation and glucose metabolism revealed by simultaneous fPET-fMRI in brain\u2019s white matter","volume":"33","author":"Li","year":"2023","journal-title":"Cereb. Cortex"},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Zhang, K., Wen, M., Nan, X., Zhao, S., Li, H., Ai, Y., and Zhu, H. (2025). NMDA receptors in neurodegenerative diseases: Mechanisms and emerging therapeutic strategies. Front. Aging Neurosci., 17.","DOI":"10.3389\/fnagi.2025.1604378"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Hadzibegovic, S., Bontempi, B., and Nicole, O. (2025). Investigating the Impact of NMDA Receptor Organization and Biological Sex in the APPswe\/PS1dE9 Mouse Model of Alzheimer\u2019s Disease. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26041737"},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Fagiani, F., Lanni, C., Racchi, M., and Govoni, S. (2021). (Dys)regulation of Synaptic Activity and Neurotransmitter Release by beta-Amyloid: A Look Beyond Alzheimer\u2019s Disease Pathogenesis. Front. Mol. Neurosci., 14.","DOI":"10.3389\/fnmol.2021.635880"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(02)00057-X","article-title":"Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: A meta-analysis","volume":"24","author":"Lyness","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"105358","DOI":"10.1016\/j.neubiorev.2023.105358","article-title":"Declining locus coeruleus-dopaminergic and noradrenergic modulation of long-term memory in aging and Alzheimer\u2019s disease","volume":"153","author":"Dahl","year":"2023","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e70087","DOI":"10.1002\/alz.70087","article-title":"Pathways underlying selective neuronal vulnerability in Alzheimer\u2019s disease: Contrasting the vulnerable locus coeruleus to the resilient substantia nigra","volume":"21","author":"Ehrenberg","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archneur.60.3.337","article-title":"Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases","volume":"60","author":"Zarow","year":"2003","journal-title":"Arch. Neurol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s13195-025-01736-4","article-title":"Repetitive prefrontal tDCS activates VTA dopaminergic neurons, resulting in attenuation of Alzheimer\u2019s Disease-like deficits in Tg2576 mice","volume":"17","author":"Loffredo","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1523\/JNEUROSCI.2044-15.2016","article-title":"On the Structure of Neuronal Population Activity under Fluctuations in Attentional State","volume":"36","author":"Ecker","year":"2016","journal-title":"J. Neurosci."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.neurobiolaging.2016.04.015","article-title":"Effects of aging on task- and stimulus-related cerebral attention networks","volume":"44","author":"Kurth","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1126\/science.7046051","article-title":"The cholinergic hypothesis of geriatric memory dysfunction","volume":"217","author":"Bartus","year":"1982","journal-title":"Science"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"e14231","DOI":"10.1111\/acel.14231","article-title":"Investigating the impact of environmental enrichment on proteome and neurotransmitter-related profiles in an animal model of Alzheimer\u2019s disease","volume":"23","author":"Nam","year":"2024","journal-title":"Aging Cell"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1101\/lm.69204","article-title":"The cholinergic lesion of Alzheimer\u2019s disease: Pivotal factor or side show?","volume":"11","author":"Mesulam","year":"2004","journal-title":"Learn. Mem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0079-6123(03)45004-8","article-title":"The cholinergic innervation of the human cerebral cortex","volume":"145","author":"Mesulam","year":"2004","journal-title":"Prog. Brain Res."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Liu, Z., Kumar, M., and Kabra, A. (2022). Cucurbitacin B exerts neuroprotection in a murine Alzheimer\u2019s disease model by modulating oxidative stress, inflammation, and neurotransmitter levels. Front. Biosci., 27.","DOI":"10.31083\/j.fbl2702071"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3233\/JAD-160763","article-title":"Role of Glutamate and NMDA Receptors in Alzheimer\u2019s Disease","volume":"57","author":"Wang","year":"2017","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1007\/s10787-025-01705-1","article-title":"Biomarkers in Alzheimer\u2019s disease: New frontiers with olfactory models","volume":"33","author":"Maheshwari","year":"2025","journal-title":"Inflammopharmacology"},{"key":"ref_111","first-page":"CD005593","article-title":"Cholinesterase inhibitors for Alzheimer\u2019s disease","volume":"2006","author":"Birks","year":"2006","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3233\/JAD-2010-1301","article-title":"Fibrillar Abeta (1-42) enhances NMDA receptor sensitivity via the integrin signaling pathway","volume":"19","author":"Uhasz","year":"2010","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.trci.2019.05.008","article-title":"Alzheimer\u2019s disease drug development pipeline: 2019","volume":"5","author":"Cummings","year":"2019","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","article-title":"Alzheimer\u2019s disease","volume":"397","author":"Scheltens","year":"2021","journal-title":"Lancet"},{"key":"ref_115","unstructured":"Sharma, N., Khatib, M.N., Roopashree, R., Kaur, M., Srivastava, M., Barwal, A., Prasad, G.V.S., Rajput, P., Mittal, V., and Shabil, M. Efficacy and Safety of the Muscarinic Receptor Agonist KarXT (Xanomeline-Trospium) in Schizophrenia: A Systematic Review, Meta-Analysis and Bayesian Sensitivity Analysis. Int. J. Neuropsychopharmacol., online ahead of print."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"105198","DOI":"10.1016\/j.nbd.2020.105198","article-title":"Deficient astrocyte metabolism impairs glutamine synthesis and neurotransmitter homeostasis in a mouse model of Alzheimer\u2019s disease","volume":"148","author":"Andersen","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Beaurain, M., Salabert, A.S., Payoux, P., Gras, E., and Talmont, F. (2024). NMDA Receptors: Distribution, Role, and Insights into Neuropsychiatric Disorders. Pharmaceuticals, 17.","DOI":"10.3390\/ph17101265"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"102331","DOI":"10.1016\/j.pneurobio.2022.102331","article-title":"Astrocyte energy and neurotransmitter metabolism in Alzheimer\u2019s disease: Integration of the glutamate\/GABA-glutamine cycle","volume":"217","author":"Andersen","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/jnc.16014","article-title":"Increased glucose metabolism and impaired glutamate transport in human astrocytes are potential early triggers of abnormal extracellular glutamate accumulation in hiPSC-derived models of Alzheimer\u2019s disease","volume":"168","author":"Salcedo","year":"2024","journal-title":"J. Neurochem."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"110828","DOI":"10.1016\/j.jocn.2024.110828","article-title":"Baseline serum glutamate: Implications for diagnosis and prediction in mild cognitive impairment and Alzheimer\u2019s disease of the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"129","author":"Gao","year":"2024","journal-title":"J. Clin. Neurosci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/153331750401900502","article-title":"Why do many NMDA antagonists fail, while others are safe and effective at blocking excitotoxicity associated with dementia and acute injury?","volume":"19","author":"Albensi","year":"2004","journal-title":"Am. J. Alzheimer\u2019s Dis. Other Demen."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11906-022-01209-1","article-title":"WNT\/beta-catenin Pathway: A Possible Link Between Hypertension and Alzheimer\u2019s Disease","volume":"24","author":"Vallee","year":"2022","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/00005072-199708000-00008","article-title":"Glutamate transporter alterations in Alzheimer disease are possibly associated with abnormal APP expression","volume":"56","author":"Li","year":"1997","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"Ortiz-Sanz, C., Gaminde-Blasco, A., Valero, J., Bakota, L., Brandt, R., Zugaza, J.L., Matute, C., and Alberdi, E. (2020). Early Effects of Abeta Oligomers on Dendritic Spine Dynamics and Arborization in Hippocampal Neurons. Front. Synaptic Neurosci., 12.","DOI":"10.3389\/fnsyn.2020.00002"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/0361073X.2024.2377440","article-title":"AMPA Receptors Endocytosis Inhibition Attenuates Cognition Deficit Via c-Fos\/BDNF Signaling in Amyloid beta Neurotoxicity","volume":"51","author":"Eyvani","year":"2025","journal-title":"Exp. Aging Res."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"e0393242024","DOI":"10.1523\/JNEUROSCI.0393-24.2024","article-title":"Amyloid-beta-Driven Synaptic Deficits Are Mediated by Synaptic Removal of GluA3-Containing AMPA Receptors","volume":"45","author":"Reinders","year":"2025","journal-title":"J. Neurosci."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: A complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"11590","DOI":"10.1074\/jbc.M607483200","article-title":"Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine","volume":"282","author":"Velasco","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/bs.pmbts.2019.04.003","article-title":"AD molecular: Molecular imaging of Alzheimer\u2019s disease: PET imaging of neurotransmitter systems","volume":"165","author":"Mecca","year":"2019","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13195-024-01385-z","article-title":"Metabotropic glutamate receptor 5 (mGluR5) is associated with neurodegeneration and amyloid deposition in Alzheimer\u2019s disease: A [(18)F]PSS232 PET\/MRI study","volume":"16","author":"Wang","year":"2024","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1146\/annurev-pharmtox-021821-091747","article-title":"Noncanonical Metabotropic Glutamate Receptor 5 Signaling in Alzheimer\u2019s Disease","volume":"62","author":"Ferguson","year":"2022","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer\u2019s disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s43856-024-00527-6","article-title":"Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer\u2019s disease patients","volume":"4","author":"Yaghmaei","year":"2024","journal-title":"Commun. Med."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: A randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"ref_135","first-page":"e70071","article-title":"Effect of long-term treatment with memantine on mortality in patients with major cognitive disorders: A systematic review and meta-analysis","volume":"11","author":"Oquendo","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Kumar, A., Dhull, D.K., and Mishra, P.S. (2015). Therapeutic potential of mGluR5 targeting in Alzheimer\u2019s disease. Front. Neurosci., 9.","DOI":"10.3389\/fnins.2015.00215"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s41420-024-01827-5","article-title":"Sulbactam protects neurons against double neurotoxicity of amyloid beta and glutamate load by upregulating glial glutamate transporter 1","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.1021\/acs.jmedchem.4c02881","article-title":"Design, Synthesis, and Pharmacological Evaluation of Nonsteroidal Tricyclic Ligands as Modulators of GABA(A) Receptors","volume":"68","author":"Xu","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"9449","DOI":"10.1007\/s12035-025-04821-9","article-title":"Use of Drugs Affecting GABA(A) Receptors and the Risk of Developing Alzheimer\u2019s Disease and Dementia: A Meta-Analysis and Literature Review","volume":"62","author":"Vakili","year":"2025","journal-title":"Mol. Neurobiol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I","article-title":"Interneurons of the hippocampus","volume":"6","author":"Freund","year":"1996","journal-title":"Hippocampus"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.neurobiolaging.2021.10.016","article-title":"Cortical network modularity changes along the course of frontotemporal and Alzheimer\u2019s dementing diseases","volume":"110","author":"Franciotti","year":"2022","journal-title":"Neurobiol. Aging"},{"key":"ref_142","doi-asserted-by":"crossref","unstructured":"Govindpani, K., Calvo-Flores Guzman, B., Vinnakota, C., Waldvogel, H.J., Faull, R.L., and Kwakowsky, A. (2017). Towards a Better Understanding of GABAergic Remodeling in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18081813"},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Leitch, B. (2024). Parvalbumin Interneuron Dysfunction in Neurological Disorders: Focus on Epilepsy and Alzheimer\u2019s Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25105549"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Traikapi, A., and Konstantinou, N. (2021). Gamma Oscillations in Alzheimer\u2019s Disease and Their Potential Therapeutic Role. Front. Syst. Neurosci., 15.","DOI":"10.3389\/fnsys.2021.782399"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"5322","DOI":"10.1038\/s41467-019-13260-9","article-title":"Optogenetic gamma stimulation rescues memory impairments in an Alzheimer\u2019s disease mouse model","volume":"10","author":"Etter","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.cell.2012.02.046","article-title":"Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model","volume":"149","author":"Verret","year":"2012","journal-title":"Cell"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/13872877251328940","article-title":"Reduced GABA(A, slow) synaptic inhibition in Alzheimer\u2019s disease","volume":"105","author":"MacIver","year":"2025","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/nan.12674","article-title":"Identification of intraneuronal amyloid beta oligomers in locus coeruleus neurons of Alzheimer\u2019s patients and their potential impact on inhibitory neurotransmitter receptors and neuronal excitability","volume":"47","author":"Kelly","year":"2021","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.neuron.2025.01.030","article-title":"BACE1-dependent cleavage of GABA(A) receptor contributes to neural hyperexcitability and disease progression in Alzheimer\u2019s disease","volume":"113","author":"Bi","year":"2025","journal-title":"Neuron"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"e13129","DOI":"10.1111\/bpa.13129","article-title":"The fate of interneurons, GABA(A) receptor sub-types and perineuronal nets in Alzheimer\u2019s disease","volume":"33","author":"Ali","year":"2023","journal-title":"Brain Pathol."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"102919","DOI":"10.1016\/j.ebiom.2020.102919","article-title":"Microglia facilitate loss of perineuronal nets in the Alzheimer\u2019s disease brain","volume":"58","author":"Crapser","year":"2020","journal-title":"EBioMedicine"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"e14504","DOI":"10.1002\/alz.14504","article-title":"Resilience to Alzheimer\u2019s disease associates with alterations in perineuronal nets","volume":"21","author":"Bahnerth","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"e6231","DOI":"10.1136\/bmj.e6231","article-title":"Benzodiazepine use and risk of dementia: Prospective population based study","volume":"345","author":"Begaud","year":"2012","journal-title":"BMJ"},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: Case-control study","volume":"349","author":"Moride","year":"2014","journal-title":"BMJ"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/gerona\/glab241","article-title":"Use of Benzodiazepines and Risk of Incident Dementia: A Retrospective Cohort Study","volume":"77","author":"Gerlach","year":"2022","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"ref_156","doi-asserted-by":"crossref","unstructured":"Wu, C.C., Liao, M.H., Su, C.H., Poly, T.N., and Lin, M.C. (2023). Benzodiazepine Use and the Risk of Dementia in the Elderly Population: An Umbrella Review of Meta-Analyses. J. Pers. Med., 13.","DOI":"10.3390\/jpm13101485"},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Capsoni, S., Arisi, I., Malerba, F., D\u2019Onofrio, M., Cattaneo, A., and Cherubini, E. (2022). Targeting the Cation-Chloride Co-Transporter NKCC1 to Re-Establish GABAergic Inhibition and an Appropriate Excitatory\/Inhibitory Balance in Selective Neuronal Circuits: A Novel Approach for the Treatment of Alzheimer\u2019s Disease. Brain Sci., 12.","DOI":"10.3390\/brainsci12060783"},{"key":"ref_158","doi-asserted-by":"crossref","unstructured":"Dharavath, R.N., Bernardo, A.M., Marceau-Linhares, C., Marcotte, M., Mezo-Gonzalez, C., Wong, K., Pina-Leblanc, C., Bouchet, A., Sharmin, D., and Pandey, K.P. (2025). \u03b15-GABA-A Receptor Positive Allosteric Modulation prevents neuronal atrophy and cognitive decline independently of p-Tau accumulation in the PS19 mouse model. bioRxiv.","DOI":"10.1101\/2024.09.07.611810"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1021\/acschemneuro.4c00714","article-title":"Reactive Astrocytes with Reduced Function of Glutamate Transporters in the App(NL-G-F) Knock-in Mice","volume":"16","author":"Srivastava","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13195-025-01672-3","article-title":"CEST imaging combined with (1)H-MRS reveal the neuroprotective effects of riluzole by improving neurotransmitter imbalances in Alzheimer\u2019s disease mice","volume":"17","author":"Shen","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"102199","DOI":"10.1016\/j.pneurobio.2021.102199","article-title":"Reactive astrocytes prevent maladaptive plasticity after ischemic stroke","volume":"209","author":"Aswendt","year":"2022","journal-title":"Prog. Neurobiol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13024-023-00682-9","article-title":"Sleep restoration by optogenetic targeting of GABAergic neurons reprograms microglia and ameliorates pathological phenotypes in an Alzheimer\u2019s disease model","volume":"18","author":"Zhao","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0197-4580(00)00100-7","article-title":"Monoamine oxidase-B inhibitors in the treatment of Alzheimer\u2019s disease","volume":"21","author":"Thomas","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"26208","DOI":"10.1021\/acsomega.5c00134","article-title":"New Prospects in the Inhibition of Monoamine Oxidase-B (MAO-B) Utilizing Propargylamine Derivatives for the Treatment of Alzheimer\u2019s Disease: A Review","volume":"10","author":"Chatzipieris","year":"2025","journal-title":"ACS Omega"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41392-025-02398-2","article-title":"Astrocytic monoamine oxidase B (MAOB)-gamma-aminobutyric acid (GABA) axis as a molecular brake on repair following spinal cord injury","volume":"10","author":"Lee","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1038\/cddis.2011.79","article-title":"Increased hippocampal CA1 density of serotonergic terminals in a triple transgenic mouse model of Alzheimer\u2019s disease: An ultrastructural study","volume":"2","author":"Noristani","year":"2011","journal-title":"Cell Death Dis."},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"527","DOI":"10.5483\/BMBRep.2023-0147","article-title":"Structural studies of serotonin receptor family","volume":"56","author":"Parajulee","year":"2023","journal-title":"BMB Rep."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1073\/pnas.0510237103","article-title":"Serotonin 1A receptors in the living brain of Alzheimer\u2019s disease patients","volume":"103","author":"Kepe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Babic Leko, M., Nikolac Perkovic, M., Spanic, E., Svob Strac, D., Pleic, N., Vogrinc, Z., Gunjaca, I., Bezovan, D., Nedic Erjavec, G., and Klepac, N. (2022). Serotonin Receptor Gene Polymorphisms Are Associated with Cerebrospinal Fluid, Genetic, and Neuropsychological Biomarkers of Alzheimer\u2019s Disease. Biomedicines, 10.","DOI":"10.3390\/biomedicines10123118"},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s13041-024-01169-4","article-title":"Serotonin enhances neurogenesis biomarkers, hippocampal volumes, and cognitive functions in Alzheimer\u2019s disease","volume":"17","author":"Azargoonjahromi","year":"2024","journal-title":"Mol. Brain"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"fcaf031","DOI":"10.1093\/braincomms\/fcaf031","article-title":"CSF biomarkers are differentially linked to brain areas high and low in noradrenaline, dopamine and serotonin across the Alzheimer\u2019s disease spectrum","volume":"7","author":"Haag","year":"2025","journal-title":"Brain Commun."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/j.neurobiolaging.2007.04.011","article-title":"Reduced 5-HT2A receptor binding in patients with mild cognitive impairment","volume":"29","author":"Hasselbalch","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"ref_173","doi-asserted-by":"crossref","unstructured":"Zheng, S., Ma, R., Yang, Y., and Li, G. (2024). Psilocybin for the treatment of Alzheimer\u2019s disease. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1420601"},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Jiang, S., Sydney, E.J., Runyan, A.M., Serpe, R., Srikanth, M., Figueroa, H.Y., Yang, M., and Myeku, N. (2024). 5-HT4 receptor agonists treatment reduces tau pathology and behavioral deficit in the PS19 mouse model of tauopathy. Front. Cell. Neurosci., 18.","DOI":"10.3389\/fncel.2024.1338502"},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"e2666","DOI":"10.1212\/WNL.0000000000010733","article-title":"Effect of escitalopram on Abeta levels and plaque load in an Alzheimer mouse model","volume":"95","author":"Cirrito","year":"2020","journal-title":"Neurology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnen\/62.12.1220","article-title":"Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease","volume":"62","author":"Jankowsky","year":"2003","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"e14579","DOI":"10.1002\/alz.14579","article-title":"SSRIs reduce plasma tau and restore dorsal raphe metabolism in Alzheimer\u2019s disease","volume":"21","author":"Terstege","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_178","doi-asserted-by":"crossref","unstructured":"Mo, M., Abzhandadze, T., Hoang, M.T., Sacuiu, S., Jurado, P.G., Pereira, J.B., Naia, L., Kele, J., Maioli, S., and Xu, H. (2025). Antidepressant use and cognitive decline in patients with dementia: A national cohort study. BMC Med., 23.","DOI":"10.1186\/s12916-025-03851-3"},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1186\/s40001-024-02006-z","article-title":"Efficacy of selective serotonin reuptake inhibitors-related antidepressants in Alzheimer\u2019s disease: A meta-analysis","volume":"29","author":"Wang","year":"2024","journal-title":"Eur. J. Med. Res."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.neuropharm.2015.02.027","article-title":"Time-dependent modulation of glutamate synapses onto 5-HT neurons by antidepressant treatment","volume":"95","author":"Geddes","year":"2015","journal-title":"Neuropharmacology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s00894-024-06134-5","article-title":"Predicting biological activity and design of 5-HT(6) antagonists through assessment of ANN-QSAR models in the context of Alzheimer\u2019s disease","volume":"30","author":"Chiari","year":"2024","journal-title":"J. Mol. Model."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"108099","DOI":"10.1016\/j.neuropharm.2020.108099","article-title":"Dual-acting agents for improving cognition and real-world function in Alzheimer\u2019s disease: Focus on 5-HT6 and D3 receptors as hubs","volume":"177","author":"Millan","year":"2020","journal-title":"Neuropharmacology"},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.1021\/jm5003952","article-title":"Serotonin 5-HT6 receptor antagonists for the treatment of cognitive deficiency in Alzheimer\u2019s disease","volume":"57","author":"Benhamu","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1021\/acs.jmedchem.3c02148","article-title":"First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT(6) Agents with a Beneficial Neuroprotective Profile against Alzheimer\u2019s Disease","volume":"67","author":"Pyka","year":"2024","journal-title":"J. Med. Chem."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1038\/srep41293","article-title":"A new serotonin 5-HT(6) receptor antagonist with procognitive activity\u2014Importance of a halogen bond interaction to stabilize the binding","volume":"7","author":"Medina","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Xing, C., Chen, H., Bi, W., Lei, T., Hang, Z., and Du, H. (2024). Targeting 5-HT Is a Potential Therapeutic Strategy for Neurodegenerative Diseases. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252413446"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-024-01660-z","article-title":"Neuronal CD59 isoforms IRIS-1 and IRIS-2 as regulators of neurotransmitter release with implications for Alzheimer\u2019s disease","volume":"17","author":"Golec","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s10020-022-00497-2","article-title":"Central nervous system effects of 5-HT(7) receptors: A potential target for neurodegenerative diseases","volume":"28","year":"2022","journal-title":"Mol. Med."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1126\/science.abm7285","article-title":"Cryo-EM structures of amyloid-beta 42 filaments from human brains","volume":"375","author":"Yang","year":"2022","journal-title":"Science"},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"2500351","DOI":"10.1002\/smsc.202500351","article-title":"Nanoscale Analysis beyond Imaging by Atomic Force Microscopy: Molecular Perspectives on Oncology and Neurodegeneration","volume":"5","author":"Marcuello","year":"2025","journal-title":"Small Sci."},{"key":"ref_191","doi-asserted-by":"crossref","unstructured":"Martorana, A., and Koch, G. (2014). \u201cIs dopamine involved in Alzheimer\u2019s disease?\u201d. Front. Aging Neurosci., 6.","DOI":"10.3389\/fnagi.2014.00252"},{"key":"ref_192","doi-asserted-by":"crossref","unstructured":"Dong, J., Wei, X., Huang, Z., Tian, J., and Zhang, W. (2024). Age-related changes of dopamine D1 and D2 receptors expression in parvalbumin-positive cells of the orbitofrontal and prelimbic cortices of mice. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1364067"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"e1278","DOI":"10.1212\/WNL.0000000000200891","article-title":"Longitudinal Dopamine D2 Receptor Changes and Cerebrovascular Health in Aging","volume":"99","author":"Karalija","year":"2022","journal-title":"Neurology"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/(SICI)1098-2396(199809)30:1<56::AID-SYN7>3.0.CO;2-J","article-title":"Age-dependent decline of dopamine D1 receptors in human brain: A PET study","volume":"30","author":"Wang","year":"1998","journal-title":"Synapse"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.4103\/NRR.NRR-D-24-00230","article-title":"The dopaminergic system and Alzheimer\u2019s disease","volume":"20","author":"Zhang","year":"2025","journal-title":"Neural Regen. Res."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"349","DOI":"10.14336\/AD.2015.0330","article-title":"Dopamine Receptors and Neurodegeneration","volume":"6","author":"Coronel","year":"2015","journal-title":"Aging Dis."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3233\/JAD-215316","article-title":"Cerebral Volumetric Correlates of Apathy in Alzheimer\u2019s Disease and Cognitively Normal Older Adults: Meta-Analysis, Label-Based Review, and Study of an Independent Cohort","volume":"85","author":"Chaudhary","year":"2022","journal-title":"J. Alzheimer\u2019s Dis."},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1159\/000509278","article-title":"Apathy in Alzheimer\u2019s Disease Correlates with the Dopamine Transporter Level in the Caudate Nuclei","volume":"10","author":"Udo","year":"2020","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/cne.903480105","article-title":"Loss of dopamine D2 receptors varies along the rostrocaudal axis of the hippocampal complex in Alzheimer\u2019s disease","volume":"348","author":"Ryoo","year":"1994","journal-title":"J. Comp. Neurol."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuroscience.2014.06.027","article-title":"Alterations in the hippocampal and striatal catecholaminergic fiber densities of heterozygous reeler mice","volume":"275","author":"Nullmeier","year":"2014","journal-title":"Neuroscience"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"101409","DOI":"10.1016\/j.lanepe.2025.101409","article-title":"Safety and efficacy of rotigotine in patients with frontotemporal dementia: A phase 2, double-blind, randomized, placebo-controlled, multicenter trial","volume":"57","author":"Koch","year":"2025","journal-title":"Lancet Reg. Health Eur."},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"e2010372","DOI":"10.1001\/jamanetworkopen.2020.10372","article-title":"Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial","volume":"3","author":"Koch","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Hauser, R.A., Slawek, J., Barone, P., Dohin, E., Surmann, E., Asgharnejad, M., and Bauer, L. (2016). Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson\u2019s disease. BMC Neurol., 16.","DOI":"10.1186\/s12883-016-0610-7"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1590\/S1980-5764-2016DN1002013","article-title":"Adjuvant transcranial direct current stimulation for treating Alzheimer\u2019s disease: A case study","volume":"10","author":"Andrade","year":"2016","journal-title":"Dement. Neuropsychol."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"133","DOI":"10.2147\/DDDT.S432170","article-title":"In vitro and in vivo Biological Evaluation of Newly Tacrine-Selegiline Hybrids as Multi-Target Inhibitors of Cholinesterases and Monoamine Oxidases for Alzheimer\u2019s Disease","volume":"18","author":"Huang","year":"2024","journal-title":"Drug Des. Dev. Ther."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/s41387-024-00317-y","article-title":"Anti-obesity effect of irreversible MAO-B inhibitors in patients with Parkinson\u2019s disease","volume":"14","author":"Liang","year":"2024","journal-title":"Nutr. Diabetes"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"eaav0316","DOI":"10.1126\/sciadv.aav0316","article-title":"Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer\u2019s disease","volume":"5","author":"Park","year":"2019","journal-title":"Sci. Adv."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Wang, W., Li, R., Li, C., Liang, Q., and Gao, X. (2024). Advances in VNS efficiency and mechanisms of action on cognitive functions. Front. Physiol., 15.","DOI":"10.3389\/fphys.2024.1452490"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gps.545","article-title":"The effect of selegiline in the treatment of people with Alzheimer\u2019s disease: A meta-analysis of published trials","volume":"17","author":"Wilcock","year":"2002","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"e3599","DOI":"10.1002\/brb3.3599","article-title":"Protective effects of selegiline against amyloid beta-induced anxiety-like behavior and memory impairment","volume":"14","author":"Mohamadpour","year":"2024","journal-title":"Brain Behav."},{"key":"ref_211","first-page":"273","article-title":"Effects and Safety of Monoamine Oxidase-B Inhibitors for Early Parkinson\u2019s Disease: A Network Meta-Analysis","volume":"87","author":"Wang","year":"2024","journal-title":"Eur. Neurol."},{"key":"ref_212","doi-asserted-by":"crossref","unstructured":"Zong, B., Yu, F., Zhang, X., Zhao, W., Sun, P., Li, S., and Li, L. (2022). Understanding How Physical Exercise Improves Alzheimer\u2019s Disease: Cholinergic and Monoaminergic Systems. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.869507"},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"eadk1822","DOI":"10.1126\/scisignal.adk1822","article-title":"The dopaminergic system promotes neprilysin-mediated degradation of amyloid-beta in the brain","volume":"17","author":"Watamura","year":"2024","journal-title":"Sci. Signal."},{"key":"ref_214","doi-asserted-by":"crossref","unstructured":"Ben Ezzdine, L., Dhahbi, W., Dergaa, I., Ceylan, H.I., Guelmami, N., Ben Saad, H., Chamari, K., Stefanica, V., and El Omri, A. (2025). Physical activity and neuroplasticity in neurodegenerative disorders: A comprehensive review of exercise interventions, cognitive training, and AI applications. Front. Neurosci., 19.","DOI":"10.3389\/fnins.2025.1502417"},{"key":"ref_215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s41531-024-00641-1","article-title":"Intense exercise increases dopamine transporter and neuromelanin concentrations in the substantia nigra in Parkinson\u2019s disease","volume":"10","author":"Hoye","year":"2024","journal-title":"npj Park. Dis."},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"149643","DOI":"10.1016\/j.brainres.2025.149643","article-title":"The neuroplastic brain: Current breakthroughs and emerging frontiers","volume":"1858","author":"Gazerani","year":"2025","journal-title":"Brain Res."},{"key":"ref_217","doi-asserted-by":"crossref","unstructured":"Hu, J., Huang, B., and Chen, K. (2024). The impact of physical exercise on neuroinflammation mechanism in Alzheimer\u2019s disease. Front. Aging Neurosci., 16.","DOI":"10.3389\/fnagi.2024.1444716"},{"key":"ref_218","doi-asserted-by":"crossref","unstructured":"Li, X., Qu, X., Shi, K., Yang, Y., and Sun, J. (2024). Physical exercise for brain plasticity promotion an overview of the underlying oscillatory mechanism. Front. Neurosci., 18.","DOI":"10.3389\/fnins.2024.1440975"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"112539","DOI":"10.1016\/j.exger.2024.112539","article-title":"Beneficial effects of physical exercise on cognitive-behavioral impairments and brain-derived neurotrophic factor alteration in the limbic system induced by neurodegeneration","volume":"195","author":"Sanaeifar","year":"2024","journal-title":"Exp. Gerontol."},{"key":"ref_220","doi-asserted-by":"crossref","unstructured":"Zou, J., and Hao, S. (2024). Exercise-induced neuroplasticity: A new perspective on rehabilitation for chronic low back pain. Front. Mol. Neurosci., 17.","DOI":"10.3389\/fnmol.2024.1407445"},{"key":"ref_221","first-page":"5","article-title":"The effect of eight weeks of walking on plasma levels of dopamine and the level of depression in elderly women with Alzheimer\u2019s disease","volume":"5","author":"Bashtani","year":"2023","journal-title":"New Approaches Exerc. Physiol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/cercor\/bhy093","article-title":"Frontal Transcranial Direct Current Stimulation Induces Dopamine Release in the Ventral Striatum in Human","volume":"28","author":"Fonteneau","year":"2018","journal-title":"Cereb. Cortex"},{"key":"ref_223","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41398-019-0443-4","article-title":"Endogenous dopamine release under transcranial direct-current stimulation governs enhanced attention: A study with positron emission tomography","volume":"9","author":"Fukai","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"ref_224","doi-asserted-by":"crossref","unstructured":"Ma, S., Zhuang, W., Wang, X., Zhang, D., Wang, H., Han, Q., Ding, Q., Li, Y., Li, W., and Li, T. (2025). Efficacy of transcranial direct current stimulation on cognitive function in patients with Parkinson\u2019s disease: A systematic review and meta-analysis. Front. Aging Neurosci., 17.","DOI":"10.3389\/fnagi.2025.1495492"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/nn1766","article-title":"What developmental disorders can tell us about the nature and origins of language","volume":"9","author":"Marcus","year":"2006","journal-title":"Nat. Neurosci."},{"key":"ref_226","doi-asserted-by":"crossref","unstructured":"Tanaka, T., Takano, Y., Tanaka, S., Hironaka, N., Kobayashi, K., Hanakawa, T., Watanabe, K., and Honda, M. (2013). Transcranial direct-current stimulation increases extracellular dopamine levels in the rat striatum. Front. Syst. Neurosci., 7.","DOI":"10.3389\/fnsys.2013.00006"},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"e095275","DOI":"10.1002\/alz.095275","article-title":"Quantitative multi-parameter mapping of locus coeruleus in aging and Alzheimer\u2019s disease","volume":"20","author":"Lenzoni","year":"2025","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s43587-024-00626-y","article-title":"Spatiotemporal patterns of locus coeruleus integrity predict cortical tau and cognition","volume":"4","author":"Bueicheku","year":"2024","journal-title":"Nat. Aging"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physrev.1992.72.1.165","article-title":"Structure and function of the brain serotonin system","volume":"72","author":"Jacobs","year":"1992","journal-title":"Physiol. Rev."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s00415-025-12932-5","article-title":"Locus coeruleus neuromelanin, cognitive dysfunction, and brain metabolism in multiple system atrophy","volume":"272","author":"Pasquini","year":"2025","journal-title":"J. Neurol."},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1016\/j.neurobiolaging.2011.06.014","article-title":"Hippocampal and ventricular changes in Parkinson\u2019s disease mild cognitive impairment","volume":"33","author":"Apostolova","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00213-008-1097-8","article-title":"Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex","volume":"200","author":"Newman","year":"2008","journal-title":"Psychopharmacology"},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.1002\/alz.14131","article-title":"Locus coeruleus integrity and neuropsychiatric symptoms in a cohort of early- and late-onset Alzheimer\u2019s disease","volume":"20","author":"Falgas","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1093\/brain\/awab452","article-title":"A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment","volume":"145","author":"Levey","year":"2022","journal-title":"Brain"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","article-title":"Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit\/hyperactivity disorder","volume":"27","author":"Bymaster","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"ref_236","doi-asserted-by":"crossref","first-page":"13011","DOI":"10.1038\/s41598-019-49609-9","article-title":"Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells","volume":"9","author":"Corona","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_237","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neuropharm.2012.07.020","article-title":"Atomoxetine modulates spontaneous and sensory-evoked discharge of locus coeruleus noradrenergic neurons","volume":"64","author":"Bari","year":"2013","journal-title":"Neuropharmacology"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1093\/brain\/awab142","article-title":"Locus coeruleus integrity and the effect of atomoxetine on response inhibition in Parkinson\u2019s disease","volume":"144","author":"Hezemans","year":"2021","journal-title":"Brain"},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"18955","DOI":"10.1038\/s41598-024-69666-z","article-title":"Vagus nerve stimulation during training fails to improve learning in healthy rats","volume":"14","author":"Carroll","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_240","doi-asserted-by":"crossref","first-page":"112975","DOI":"10.1016\/j.expneurol.2019.112975","article-title":"Norepinephrine and serotonin are required for vagus nerve stimulation directed cortical plasticity","volume":"320","author":"Hulsey","year":"2019","journal-title":"Exp. Neurol."},{"key":"ref_241","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/s41598-022-05842-3","article-title":"The potential of invasive and non-invasive vagus nerve stimulation to improve verbal memory performance in epilepsy patients","volume":"12","author":"Mertens","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_242","doi-asserted-by":"crossref","unstructured":"Sharma, B., Jones, K.A., Olsen, L.K., Moore, R.J., Curtner, F.S., and Hatcher-Solis, C.N. (2025). Vagus nerve stimulation ameliorates cognitive impairment caused by hypoxia. Front. Behav. Neurosci., 19.","DOI":"10.3389\/fnbeh.2025.1555229"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2147\/NDT.S465249","article-title":"Vagus Nerve Stimulation for Improvement of Vascular Cognitive Impairment","volume":"20","author":"Ridengnaxi","year":"2024","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"ref_244","doi-asserted-by":"crossref","first-page":"e14420","DOI":"10.1111\/acel.14420","article-title":"Long-term exposure to excessive norepinephrine in the brain induces tau aggregation, neuronal death, and cognitive deficits in early tau transgenic mice","volume":"24","author":"Jeong","year":"2025","journal-title":"Aging Cell"},{"key":"ref_245","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.neurobiolaging.2005.06.010","article-title":"Cooexpression of FTDP-17 tau and GSK-3beta in transgenic mice induce tau polymerization and neurodegeneration","volume":"27","author":"Engel","year":"2006","journal-title":"Neurobiol. Aging"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"eadr8055","DOI":"10.1126\/sciadv.adr8055","article-title":"Monoaminergic neurotransmitters are bimodal effectors of tau aggregation","volume":"11","author":"Chang","year":"2025","journal-title":"Sci. Adv."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1172\/JCI130513","article-title":"Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus","volume":"130","author":"Kang","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_248","doi-asserted-by":"crossref","first-page":"153","DOI":"10.2174\/156802610790411027","article-title":"Histamine H3 antagonists for treatment of cognitive deficits in CNS diseases","volume":"10","author":"Raddatz","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1152\/physrev.00043.2007","article-title":"Histamine in the nervous system","volume":"88","author":"Haas","year":"2008","journal-title":"Physiol. Rev."},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"e12379","DOI":"10.1002\/trc2.12379","article-title":"Histaminergic neurotransmission in aging and Alzheimer\u2019s disease: A review of therapeutic opportunities and gaps","volume":"9","author":"Satpati","year":"2023","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_251","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1124\/jpet.110.171306","article-title":"The histamine H3 receptor and eating behavior","volume":"336","author":"Passani","year":"2011","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41398-025-03358-8","article-title":"Pitolisant alleviates brain network dysfunction and cognitive deficits in a mouse model of Alzheimer\u2019s disease","volume":"15","author":"Zou","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1038\/s41598-022-11032-y","article-title":"The impact of pitolisant, an H(3) receptor antagonist\/inverse agonist, on perirhinal cortex activity in individual neuron and neuronal population levels","volume":"12","author":"Hirano","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_254","doi-asserted-by":"crossref","unstructured":"Vohora, D., and Bhowmik, M. (2012). Histamine H3 receptor antagonists\/inverse agonists on cognitive and motor processes: Relevance to Alzheimer\u2019s disease, ADHD, schizophrenia, and drug abuse. Front. Syst. Neurosci., 6.","DOI":"10.3389\/fnsys.2012.00072"},{"key":"ref_255","doi-asserted-by":"crossref","unstructured":"Perez-Silanes, S., Martisova, E., Moreno, E., Solas, M., Plano, D., Sanmartin, C., and Ramirez, M.J. (2024). Novel Pitolisant-Derived Sulfonyl Compounds for Alzheimer Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25020799"},{"key":"ref_256","doi-asserted-by":"crossref","first-page":"S622","DOI":"10.1067\/mai.2000.106153","article-title":"The effects of antihistamines on cognition and performance","volume":"105","author":"Kay","year":"2000","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_257","doi-asserted-by":"crossref","unstructured":"Yang, C.C., Chien, W.C., Chung, C.H., Lai, C.Y., and Tzeng, N.S. (2022). The Usage of Histamine Type 1 Receptor Antagonist and Risk of Dementia in the Elderly: A Nationwide Cohort Study. Front. Aging Neurosci., 14.","DOI":"10.3389\/fnagi.2022.811494"},{"key":"ref_258","first-page":"639","article-title":"A systematic review of amnestic and non-amnestic mild cognitive impairment induced by anticholinergic, antihistamine, GABAergic and opioid drugs","volume":"29","author":"Tannenbaum","year":"2012","journal-title":"Drugs Aging"},{"key":"ref_259","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s00403-011-1192-2","article-title":"Effects of single therapeutic doses of promethazine, fexofenadine and olopatadine on psychomotor function and histamine-induced wheal- and flare-responses: A randomized double-blind, placebo-controlled study in healthy volunteers","volume":"304","author":"Kamei","year":"2012","journal-title":"Arch. Dermatol. Res."},{"key":"ref_260","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/01.smj.0000221631.98056.87","article-title":"Efficacy and central nervous system impairment of newer-generation prescription antihistamines in seasonal allergic rhinitis","volume":"99","author":"Spangler","year":"2006","journal-title":"South Med. J."},{"key":"ref_261","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1742-2094-9-90","article-title":"Histamine modulates microglia function","volume":"9","author":"Ferreira","year":"2012","journal-title":"J. Neuroinflamm."},{"key":"ref_262","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbi.2016.07.002","article-title":"Histamine regulation of microglia: Gene-environment interaction in the regulation of central nervous system inflammation","volume":"57","author":"Frick","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"ref_263","doi-asserted-by":"crossref","first-page":"25519","DOI":"10.1038\/s41598-024-75982-1","article-title":"Histamine stimulates human microglia to alter cellular prion protein expression via the HRH2 histamine receptor","volume":"14","author":"Pehar","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_264","doi-asserted-by":"crossref","first-page":"2398212818817494","DOI":"10.1177\/2398212818817494","article-title":"Purine and purinergic receptors","volume":"2","author":"Burnstock","year":"2018","journal-title":"Brain Neurosci. Adv."},{"key":"ref_265","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/brain\/awae113","article-title":"Neuronal A2A receptor exacerbates synapse loss and memory deficits in APP\/PS1 mice","volume":"147","author":"Launay","year":"2024","journal-title":"Brain"},{"key":"ref_266","doi-asserted-by":"crossref","unstructured":"Martinez-Frailes, C., Di Lauro, C., Bianchi, C., de Diego-Garcia, L., Sebastian-Serrano, A., Bosca, L., and Diaz-Hernandez, M. (2019). Amyloid Peptide Induced Neuroinflammation Increases the P2X7 Receptor Expression in Microglial Cells, Impacting on Its Functionality. Front. Cell. Neurosci., 13.","DOI":"10.3389\/fncel.2019.00143"},{"key":"ref_267","doi-asserted-by":"crossref","first-page":"6475","DOI":"10.1038\/s41598-019-42931-2","article-title":"Amyloid beta-dependent mitochondrial toxicity in mouse microglia requires P2X7 receptor expression and is prevented by nimodipine","volume":"9","author":"Chiozzi","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_268","doi-asserted-by":"crossref","first-page":"e925491","DOI":"10.12659\/MSM.925491","article-title":"P2X7 Receptor (P2X7R) of Microglia Mediates Neuroinflammation by Regulating (NOD)-Like Receptor Protein 3 (NLRP3) Inflammasome-Dependent Inflammation After Spinal Cord Injury","volume":"26","author":"Fan","year":"2020","journal-title":"Med. Sci. Monit."},{"key":"ref_269","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1523\/JNEUROSCI.5512-08.2009","article-title":"The P2X7 receptor drives microglial activation and proliferation: A trophic role for P2X7R pore","volume":"29","author":"Monif","year":"2009","journal-title":"J. Neurosci."},{"key":"ref_270","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/s41467-025-60806-1","article-title":"Glial reactivity correlates with synaptic dysfunction across aging and Alzheimer\u2019s disease","volume":"16","author":"Rohden","year":"2025","journal-title":"Nat. Commun."},{"key":"ref_271","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuropharm.2015.08.046","article-title":"Adenosinergic signaling in epilepsy","volume":"104","author":"Boison","year":"2016","journal-title":"Neuropharmacology"},{"key":"ref_272","doi-asserted-by":"crossref","unstructured":"Boison, D. (2016). The Biochemistry and Epigenetics of Epilepsy: Focus on Adenosine and Glycine. Front. Mol. Neurosci., 9.","DOI":"10.3389\/fnmol.2016.00026"},{"key":"ref_273","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s11302-022-09883-1","article-title":"Adenosine receptor signalling in Alzheimer\u2019s disease","volume":"18","author":"Trinh","year":"2022","journal-title":"Purinergic Signal."},{"key":"ref_274","doi-asserted-by":"crossref","first-page":"83","DOI":"10.15280\/jlm.2023.13.2.83","article-title":"Effect of Daily Coffee Consumption on the Risk of Alzheimer\u2019s Disease: A Systematic Review and Meta-Analysis","volume":"13","author":"Nila","year":"2023","journal-title":"J. Lifestyle Med."},{"key":"ref_275","doi-asserted-by":"crossref","unstructured":"Merighi, S., Travagli, A., Nigro, M., Pasquini, S., Cappello, M., Contri, C., Varani, K., Vincenzi, F., Borea, P.A., and Gessi, S. (2023). Caffeine for Prevention of Alzheimer\u2019s Disease: Is the A(2A) Adenosine Receptor Its Target?. Biomolecules, 13.","DOI":"10.3390\/biom13060967"},{"key":"ref_276","doi-asserted-by":"crossref","unstructured":"Song, X., Singh, M., Lee, K.E., Vinayagam, R., and Kang, S.G. (2024). Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212003"},{"key":"ref_277","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00213-013-3158-x","article-title":"Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex","volume":"230","author":"Kobayashi","year":"2013","journal-title":"Psychopharmacology"},{"key":"ref_278","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.cjtee.2023.08.003","article-title":"Targeting the adenosine A(2A) receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson\u2019s disease","volume":"27","author":"Zhao","year":"2024","journal-title":"Chin. J. Traumatol."},{"key":"ref_279","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"key":"ref_280","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.coph.2006.11.001","article-title":"In vivo neurochemical effects induced by changes in endocannabinoid neurotransmission","volume":"7","author":"Degroot","year":"2007","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_281","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","year":"2012","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"ref_282","doi-asserted-by":"crossref","unstructured":"Young, A.P., and Denovan-Wright, E.M. (2021). The Dynamic Role of Microglia and the Endocannabinoid System in Neuroinflammation. Front. Pharmacol., 12.","DOI":"10.3389\/fphar.2021.806417"},{"key":"ref_283","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-2-29","article-title":"Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation","volume":"2","author":"Ehrhart","year":"2005","journal-title":"J. Neuroinflamm."},{"key":"ref_284","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/s41419-024-07249-6","article-title":"Microglial cannabinoid receptor type II stimulation improves cognitive impairment and neuroinflammation in Alzheimer\u2019s disease mice by controlling astrocyte activation","volume":"15","author":"Sobue","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_285","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.mad.2015.08.005","article-title":"Age-related changes in the endocannabinoid system in the mouse hippocampus","volume":"150","author":"Piyanova","year":"2015","journal-title":"Mech. Ageing Dev."},{"key":"ref_286","doi-asserted-by":"crossref","unstructured":"Kanwal, H., Sangineto, M., Ciarnelli, M., Castaldo, P., Villani, R., Romano, A.D., Serviddio, G., and Cassano, T. (2024). Potential Therapeutic Targets to Modulate the Endocannabinoid System in Alzheimer\u2019s Disease. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25074050"},{"key":"ref_287","doi-asserted-by":"crossref","unstructured":"Armeli, F., Coccurello, R., Giacovazzo, G., Mengoni, B., Paoletti, I., Oddi, S., Maccarrone, M., and Businaro, R. (2024). FAAH Inhibition Counteracts Neuroinflammation via Autophagy Recovery in AD Models. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms252212044"},{"key":"ref_288","doi-asserted-by":"crossref","first-page":"108394","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol. Ther."},{"key":"ref_289","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.7150\/thno.106592","article-title":"Sex- and age-specific sensitivities of the endocannabinoid system in Alzheimer\u2019s disease revealed by PET imaging with [(18)F]FMPEP-d (2) and [(18)F]MAGL-2102","volume":"15","author":"Pees","year":"2025","journal-title":"Theranostics"},{"key":"ref_290","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1124\/mol.111.071290","article-title":"Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: Relevance to Alzheimer\u2019s disease","volume":"79","author":"Reigada","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"ref_291","doi-asserted-by":"crossref","unstructured":"Xiong, Y., and Lim, C.S. (2021). Understanding the Modulatory Effects of Cannabidiol on Alzheimer\u2019s Disease. Brain Sci., 11.","DOI":"10.3390\/brainsci11091211"},{"key":"ref_292","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/bs.irn.2024.04.014","article-title":"Cannabidiol and Alzheimer\u2019s disease","volume":"177","author":"Marques","year":"2024","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_293","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s13195-025-01756-0","article-title":"Cannabidiol as a multifaceted therapeutic agent: Mitigating Alzheimer\u2019s disease pathology and enhancing cognitive function","volume":"17","author":"Raich","year":"2025","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"ref_294","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1177\/25424823241284464","article-title":"A systematic study of molecular targets of cannabidiol in Alzheimer\u2019s disease","volume":"8","author":"Patil","year":"2024","journal-title":"J. Alzheimer\u2019s Dis. Rep."},{"key":"ref_295","first-page":"53","article-title":"Oral THC: CBD cannabis extract in main symptoms of Alzheimer disease: Agitation and weight loss","volume":"174","author":"Palmieri","year":"2023","journal-title":"Clin. Ter."},{"key":"ref_296","doi-asserted-by":"crossref","first-page":"49087","DOI":"10.4088\/JCP.23m14791","article-title":"The Use of Dispensary-Obtained Tetrahydrocannabinol as a Treatment for Neuropsychiatric Symptoms of Dementia","volume":"84","author":"Sawicki","year":"2023","journal-title":"J. Clin. Psychiatry"},{"key":"ref_297","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1212\/WNL.0000000000001675","article-title":"Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial","volume":"84","author":"Ahmed","year":"2015","journal-title":"Neurology"},{"key":"ref_298","doi-asserted-by":"crossref","first-page":"e3514348461","DOI":"10.33448\/rsd-v14i3.48461","article-title":"Canabidiol e THC no tratamento da Doen\u00e7a de Alzheimer: Uma revis\u00e3o integrativa da literatura","volume":"14","author":"Pereira","year":"2025","journal-title":"Res. Soc. Dev."},{"key":"ref_299","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.amjmed.2025.06.025","article-title":"The High Cost of Low Evidence: Why Cannabis Research Lags Behind its Use","volume":"138","author":"Kheirbek","year":"2025","journal-title":"Am. J. Med."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/3\/334\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T12:45:05Z","timestamp":1774269905000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/3\/334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,22]]},"references-count":299,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["cimb48030334"],"URL":"https:\/\/doi.org\/10.3390\/cimb48030334","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,22]]}}}